Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 10,706 shares at $1.87 ($20K) on 2022-03-02, disclosed to the SEC on 2022-03-03.
Seasonal sale ($20k) by See Remarks — this insider has traded CLVS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.87 | 290 | $542 | 2.7% |
| 2 | $1.87 | 10,416 | $19K | 97.3% |
| Total | $1.87 avg | 10,706 | $20K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |